Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab + Methotrexate in Polyarticular JRA
NCT00036374Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2001
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in juvenile idiopathic arthritis (JIA), sponsored by Janssen Pharmaceutical. Started Oct 2001; status: completed.
02
Drugs
infliximab
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT00036374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036374.